Pakistan has lifted the ban it had imposed on importing Indian medicines and medicinal raw materials to prevent shortages, Economic Times has reported.
This development comes after the nation’s pharmaceutical industry’s also demanded a review of the ban while claiming that such an embargo may potentially cause a severe shortage of medicines in the country.
A pharmaceutical body also warned that any attempt to disrupt the global supply chains related to the country’s pharma industry will hamper the country’s ability to treat Covid-19 cases.
The country is currently importing various vitamins like B1, B2, B6, B12, D3 and zinc sulphate monohydrate, drugs and medicinal salts from India. The imports also include various vaccines for polio, tuberculosis and tetanus.
Pakistan had placed a blanket ban on all imports from India following the abrogation of Article 370 in Jammu and Kashmir.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!